Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹800 Cr₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹800 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹800 Cr
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr
Mar2021₹384 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹800 Cr
-24.74
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr
-5.96
Mar2021 ₹384 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,945.5 Cr 1.7% 7.3% 24.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,644.0 Cr 1.1% 7.2% 15.4% Stock Analytics
DIVIS LABORATORIES ₹184,053.0 Cr 2.4% 4.2% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹167,464.0 Cr 1.9% 8.3% 45.6% Stock Analytics
CIPLA ₹115,263.0 Cr -1.8% 3.2% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,049.0 Cr -8.8% -3.2% -4.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.7%

7.3%

24.6%

SENSEX

-0.9%

4.9%

-6.8%


You may also like the below Video Courses